ARTICLE | Company News
Eisai completes German pricing negotiations for Halaven
October 17, 2012 12:45 AM UTC
Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) reached an agreement on the price for breast cancer drug Halaven eribulin with Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband). The ...